10 insiders reported 159 Form 4 transactions for Enliven Therapeutics, Inc. (ELVN) over the past 18 months (most recent 2026-06-24). Recent activity: OrbiMed Genesis GP LLC (Insider) Sell 24,846 shares, OrbiMed Capital GP VII LLC (Insider) Sell 24,846 shares, ORBIMED ADVISORS LLC (Insider) Sell 24,846 shares, OrbiMed Genesis GP LLC (Insider) Sell 1,477 shares, OrbiMed Capital GP VII LLC (Insider) Sell 1,477 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | OrbiMed Genesis GP LLC | Insider | Sell | 24,846 | $1.1M |
| 2026-06-24 | OrbiMed Capital GP VII LLC | Insider | Sell | 24,846 | $1.1M |
| 2026-06-24 | ORBIMED ADVISORS LLC | Insider | Sell | 24,846 | $1.1M |
| 2026-06-24 | OrbiMed Genesis GP LLC | Insider | Sell | 1,477 | $66,465 |
| 2026-06-24 | OrbiMed Capital GP VII LLC | Insider | Sell | 1,477 | $66,465 |
| 2026-06-24 | ORBIMED ADVISORS LLC | Insider | Sell | 1,477 | $66,465 |
| 2026-06-24 | OrbiMed Genesis GP LLC | Insider | Sell | 787,024 | $35.7M |
| 2026-06-24 | OrbiMed Capital GP VII LLC | Insider | Sell | 787,024 | $35.7M |
| 2026-06-24 | ORBIMED ADVISORS LLC | Insider | Sell | 787,024 | $35.7M |
| 2026-06-24 | ORBIMED ADVISORS LLC | Insider | Sell | 46,776 | $2.1M |
| 2026-06-24 | OrbiMed Genesis GP LLC | Insider | Sell | 46,776 | $2.1M |
| 2026-06-24 | OrbiMed Capital GP VII LLC | Insider | Sell | 46,776 | $2.1M |
| 2026-06-22 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-06-22 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Buy | 6,018 | $14,925 |
| 2026-06-22 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 1,268 | $54,305 |
| 2026-06-22 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,379 | $59,001 |
| 2026-06-22 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 2,599 | $114,018 |
| 2026-06-22 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,401 | $149,179 |
| 2026-06-22 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 1,133 | $50,694 |
| 2026-06-22 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,238 | $55,397 |
| 2026-06-17 | OrbiMed Genesis GP LLC | Insider | Sell | 9,086 | $409,052 |
| 2026-06-17 | OrbiMed Capital GP VII LLC | Insider | Sell | 9,086 | $409,052 |
| 2026-06-17 | ORBIMED ADVISORS LLC | Insider | Sell | 9,086 | $409,052 |
| 2026-06-17 | OrbiMed Genesis GP LLC | Insider | Sell | 272,322 | $12.3M |
| 2026-06-17 | OrbiMed Capital GP VII LLC | Insider | Sell | 272,322 | $12.3M |
Source: SEC Form 4 filings · as of 2026-06-24